| Guidelines for the optimal design of miRNA-based shRNAs X Bofill-De Ros, S Gu Methods 103, 157-166, 2016 | 92 | 2016 |
| 3′ Uridylation Confers miRNAs with Non-canonical Target Repertoires A Yang¶, X Bofill-De Ros¶, TJ Shao, M Jiang, K Li, P Villanueva, L Dai, ... Molecular cell, 2019 | 75 | 2019 |
| AGO-bound mature miRNAs are oligouridylated by TUTs and subsequently degraded by DIS3L2 A Yang¶, TJ Shao¶, X Bofill-De Ros¶, C Lian, P Villanueva, L Dai, S Gu Nature communications 11 (1), 1-13, 2020 | 69 | 2020 |
| DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth J Luna, J Boni, M Cuatrecasas, X Bofill-De Ros, E Núñez-Manchón, ... Gut 68 (8), 1465-1476, 2019 | 61 | 2019 |
| Structural differences between Pri-miRNA paralogs promote alternative drosha cleavage and expand target repertoires X Bofill-De Ros, WK Kasprzak, Y Bhandari, L Fan, Q Cavanaugh, M Jiang, ... Cell reports 26 (2), 447-459. e4, 2019 | 59 | 2019 |
| IsomiRs: expanding the miRNA repression toolbox beyond the seed X Bofill-De Ros, A Yang, S Gu Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1863 (4), 194373, 2020 | 57 | 2020 |
| Stress-induced microRNA-708 impairs β-cell function and growth J Rodríguez-Comas, A Moreno-Asso, J Moreno-Vedia, M Martín, ... Diabetes 66 (12), 3029-3040, 2017 | 52 | 2017 |
| miR-148a-and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity X Bofill-De Ros, M Gironella, C Fillat Molecular Therapy 22 (9), 1665-1677, 2014 | 42 | 2014 |
| Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop API T Desvignes, P Loher, K Eilbeck, J Ma, G Urgese, B Fromm, J Sydes, ... Bioinformatics 36 (3), 698-703, 2020 | 39 | 2020 |
| Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges X Bofill-De Ros, M Santos, M Vila-Casadesús, E Villanueva, N Andreu, ... BMC genomics 16, 1-12, 2015 | 33 | 2015 |
| Implications of MicroRNAs in Oncolytic Virotherapy X Bofill-De Ros, M Rovira-Rigau, C Fillat Frontiers in oncology 7, 142, 2017 | 31 | 2017 |
| QuagmiR: A Cloud-based Application for IsomiR Big Data Analytics X Bofill-De Ros, K Chen, S Chen, N Tesic, D Randjelovic, N Skundric, ... Bioinformatics, 2018 | 20 | 2018 |
| Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells X Bofill-De Ros¶, E Villanueva¶, C Fillat Oncotarget 6 (8), 6179, 2015 | 19 | 2015 |
| TENT2, TUT4, and TUT7 selectively regulate miRNA sequence and abundance A Yang¶, X Bofill-De Ros¶, R Stanton, TJ Shao, P Villanueva, S Gu Nature Communications 13 (1), 5260, 2022 | 18 | 2022 |
| Tumor IsomiR Encyclopedia (TIE): a pancancer database of miRNA isoforms X Bofill-De Ros¶, B Luke, R Guthridge, U Mudunuri, M Loss, S Gu¶ Bioinformatics, 2021 | 15 | 2021 |
| Pancreatic cancer gene therapy: from molecular targets to delivery systems C Fillat, A Jose, X Bofill-De Ros, A Mato-Berciano, MV Maliandi, ... Cancers 3 (1), 368-395, 2011 | 11 | 2011 |
| Controlling adenoviral replication to induce oncolytic efficacy C Fillat, A José, BD Ros, A Mato-Berciano, M Victoria Maliandi, ... The Open Gene Therapy Journal 3 (1), 2010 | 8 | 2010 |
| Flexible pri-miRNA structures enable tunable production of 5’isomiRs X Bofill-De Ros, Z Hong, B Birkenfeld, S Alamo-Ortiz, A Yang, L Dai, S Gu RNA biology 19 (1), 279-289, 2022 | 6 | 2022 |
| Novel, abundant Drosha isoforms are deficient in miRNA processing in cancer cells L Dai, L Hallmark, X Bofill-De Ros, H Crouch, S Chen, T Shi, A Yang, ... RNA biology, 2020 | 4 | 2020 |
| Recent progress in miRNA biogenesis and decay X Bofill-De Ros, UA Vang Ørom RNA biology 21 (1), 1-8, 2024 | 3 | 2024 |
Shuo GuNIH Stadtman Investigator, RNA Biology Laboratory, NIH/NCIVerified email at nih.gov
